Trending

#mprev

Latest posts tagged with #mprev on Bluesky

Latest Top
Trending

Posts tagged #mprev

Preview
Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study - Journal of Epidemiology and Global ... Journal of Epidemiology and Global Health - Immunocompromised individuals are at substantially increased risk of severe acute respiratory infection (SARI), often compounded by inadequate response...

Changing Prevalence of Immunocompromising Conditions in Patients Hospitalized with Severe Acute Respiratory Infection in Europe: Insights from the COVIDRIVE Study link.springer.com/article/10.1... #hvhebron #mprev [Text complet]

0 0 0 0
Preview
Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria Introduction: In July 2021, the European Medicines Agency issued a warning about reports of Guillain-Barré syndrome (GBS) following COVID-19 vaccinati…

Validation of Guillain-Barré syndrome case identification in three heterogeneous VAC4EU real-world data sources in Spain using the Brighton Collaboration criteria www.sciencedirect.com/science/arti... #hvhebron #farm #mprev [Text complet]

0 0 0 0
Preview
Infecciones de transmisión sexual en gestantes: prevalencia, coinfección y complicaciones del embarazo Las infecciones de transmisión sexual (ITS) durante el embarazo pueden generar complicaciones materno-fetales relevantes. El papel de otros microorgan…

Infecciones de transmisión sexual en gestantes: prevalencia, coinfección y complicaciones del embarazo www.sciencedirect.com/science/arti... #hvhebron #mprev

0 0 0 0
Preview
Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform Background While multiple studies report that the BNT162b2 XBB.1.5-adapted mRNA COVID-19 vaccine (BNT162b2 XBB vaccine) is effective in preventing COVID-19 hospitalisation and death, effectiveness bey...

Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform journals.plos.org/plosone/arti... #hvhebron #micro #mprev #nimm [Text complet]

0 0 0 0
Preview
Exhausted/Senescent CD4+ T cells as Predictors of Vaccine Failure and Severe COVID-19 in Solid Organ Transplant Recipients Despite booster vaccinations, solid organ transplants (SOT) develop suboptimal immunity and remain at risk of severe COVID-19. Chronic immunosuppressi…

Exhausted/Senescent CD4+ T cells as Predictors of Vaccine Failure and Severe COVID-19 in Solid Organ Transplant Recipients www.sciencedirect.com/science/arti... #hvhebron #nefro #tras #micro #hepato #chbpt #malinf #nefroped #mprev

0 0 0 0
Preview
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage Using latent-class models in a population-based sample of MS patients, cardiovascular and psychiatric clusters were identified. Nurse visits and medication dispensation were higher in the cardiovascu...

Clusters of Comorbidities in #Multiple #Sclerosis and Their Influence on Healthcare Resource Usage onlinelibrary.wiley.com/doi/10.1111/... #hvhebron #nimm #mprev [Text complet]

0 0 0 0
Preview
Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study - BMC Infectious Diseases Background We aimed to identify risk factors for breakthrough SARS-CoV-2 infection after at least one dose of any COVID-19 vaccine. Methods This is a case-control test-negative design study in hospita...

Risk factors of COVID-19 breakthrough infection: a case-control test-negative design study bmcinfectdis.biomedcentral.com/articles/10.... #hvhebron #mprev #micro #malinf [Text complet]

0 0 0 0

Safety monitoring of GSK’s quadrivalent seasonal influenza vaccine in European countries during the 2023/24 flu season: A multicenter, non-interventional study www.tandfonline.com/doi/full/10.... #hvhebron #mprev [Text complet]

0 0 0 0

Community-based strategies for tuberculosis control in migrant communities: how to integrate determinants of vulnerability into decision-making bmcpublichealth.biomedcentral.com/articles/10.... #malinf #mprev [Text complet]

0 0 0 0
Preview
Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort - British Journal of Cancer British Journal of Cancer - Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort

Intake of total, classes, and subclasses of (poly)phenols and risk of lymphoid neoplasms: a prospective analysis in the EPIC cohort www.nature.com/articles/s41... #hvhebron #mprev

0 0 0 0

Impaired Long-Term Quantitative Cellular Response to SARS-CoV-2 Vaccine in Thiopurine-Treated IBD Patients www.mdpi.com/2073-4409/14... #hvhebron #ad #micro #mprev #imm [Text complet]

0 0 0 0
Preview
Infecciones por Mpox en pacientes vacunados. ¿Es necesaria una dosis de recuerdo?

Infecciones por Mpox en pacientes vacunados. ¿Es necesaria una dosis de recuerdo? www.sciencedirect.com/science/arti... #hvhebron #malinf #mprev

0 0 0 0
Preview
Morbilidad y uso de recursos de las personas incluidas en el programa de atención domiciliaria de la atención primaria Describir el estado de salud y uso de recursos de las personas incluidas en el programa de atención domiciliaria (ATDOM) mediante el uso secundario de…

#Morbilidad y uso de recursos de las personas incluidas en el programa de #atención #domiciliaria de la atención primaria www.sciencedirect.com/science/arti... #hvhebron #mprev [Text complet]

0 0 0 0
Preview
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study Mpox is a viral illness for which the MVA-BN vaccine was authorized during the 2022 global outbreak. Although initial studies reported high immunogeni…

Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev

0 0 0 0
Preview
Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study Mpox is a viral illness for which the MVA-BN vaccine was authorized during the 2022 global outbreak. Although initial studies reported high immunogeni…

Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study www.sciencedirect.com/science/arti... #hvhebron #malinf #micro #mprev

0 0 0 0
Preview
Inmunización frente a Haemophilus influenzae tipo b fuera del calendario sistemático de vacunación La epidemiología de la enfermedad invasiva por Haemophilus influenzae (H. influenzae) se ha modificado drásticamente desde la introducción de las vacu…

Inmunización frente a Haemophilus influenzae tipo b fuera del calendario sistemático de vacunación www.sciencedirect.com/science/arti... #hvhebron #mprev

0 0 0 0
Preview
Secular trends in periprosthetic joint infections following primary hip and knee arthroplasties: A 15-year cohort study from the VINCat Program (2008–2022) The VINCat program, established in Catalonia, Spain, in 2006, is a comprehensive infection prevention program for healthcare-associated infections. Th…

Tendencias seculares en infecciones articulares periprotésicas tras artroplastias primarias de cadera y rodilla: un estudio de cohorte de 15 años del Programa VINCat (2008-2022) www.sciencedirect.com/science/arti... #hvhebron #mprev

0 0 0 0
Preview
Trends in point-prevalence surveys of healthcare-associated infections in acute care hospitals from the VINCat program in Catalonia, Spain (2008–2022) Point prevalence surveys (PPS) offer valuable insights into the burden of healthcare-associated infections (HAIs) and antibiotic utilization. Our obje…

Tendencias en encuestas de prevalencia puntual de infecciones relacionadas con la atención sanitaria en hospitales de cuidados agudos del programa VINCat en Cataluña, España (2008–2022) www.sciencedirect.com/science/arti... #hvhebron #mprev

0 0 0 0
Preview
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization journals.sagepub.com/doi/10.1177/... #hvhebron #nimm #neuro #mprev

0 0 0 0
Preview
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS | Neurology Background and ObjectivesHepatitis B vaccination (HBV) requires 6 months to complete and is recommended for patients with multiple sclerosis (PWMS), particularly those who are candidates for anti-CD20...

Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS www.neurology.org/doi/pdf/10.1... #hvhebron #nimm #mprev #micro [Text complet]

0 0 0 0
Preview
Dose-response associations between physical activity and mental health among USA adolescents AbstractBackground. Adolescent mental health is a critical public health concern. Physical activity has been shown to reduce risk of negative mental health

Dose-response associations between physical activity and mental health among USA adolescents academic.oup.com/eurpub/artic... #hvhebron #mprev [Text complet]

0 0 0 0
Preview
Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related to the Omicron JN.1 variant than the XBB v…

Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform www.sciencedirect.com/science/arti... #hvhebron #micro #mprev #nimm [Text complet]

0 0 0 0